Conexeu Sciences is trading at $2.19, down 7.98%, with no clear catalyst identified for the November 4 decline.
- No new company-specific announcement explaining the decline was found; the latest listed releases are dated October 15 and October 6.
- Biotech was rising, and major U.S. indices were also sharply higher, so the supplied sector context does not explain the stock’s drop.